• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠致病性大肠杆菌抑制肠道维生素 B1(硫胺素)摄取:用人源肠上皮 Caco-2 细胞进行的研究。

Enteropathogenic Escherichia coli inhibits intestinal vitamin B1 (thiamin) uptake: studies with human-derived intestinal epithelial Caco-2 cells.

机构信息

Department of Medical Research, Veterans Administration Medical Center, Long Beach, California 90822, USA.

出版信息

Am J Physiol Gastrointest Liver Physiol. 2009 Oct;297(4):G825-33. doi: 10.1152/ajpgi.00250.2009. Epub 2009 Jul 23.

DOI:10.1152/ajpgi.00250.2009
PMID:19628653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2763801/
Abstract

Infection with the gram-negative enteropathogenic Escherichia coli (EPEC), a food-borne pathogen, represents a significant risk to human health. Whereas diarrhea is a major consequence of this infection, malnutrition also occurs especially in severe and prolonged cases, which may aggravate the health status of the infected hosts. Here we examined the effect of EPEC infection on the intestinal uptake of the water-soluble vitamin B1 (thiamin) using an established human intestinal epithelial Caco-2 cell model. The results showed that infecting Caco-2 cells with wild-type EPEC (but not with nonpathogenic E. coli, killed EPEC, or filtered supernatant) leads to a significant (P < 0.01) inhibition in thiamin uptake. Kinetic parameters of both the nanomolar (mediated by THTR-2) and the micromolar (mediated by THTR-1) saturable thiamin uptake processes were affected by EPEC infection. Cell surface expression of hTHTR-1 and -2 proteins, (determined by the biotinylation method) showed a significantly (P < 0.01) lower expression in EPEC-treated cells compared with controls. EPEC infection also affected the steady-state mRNA levels as well as promoter activity of the SLC19A2 and SLC19A3 genes. Infecting Caco-2 cells with EPEC mutants that harbor mutations in the escN gene (which encodes a putative ATPase for the EPEC type III secretion system, TTSS) or the espA, espB, or espD genes (which encode structural components of the TTSS) did not affect thiamin uptake. On the other hand, mutations in espF and espH genes (which encode effector proteins) exhibited partial inhibition in thiamin uptake. These results demonstrate for the first time that EPEC infection of human intestinal epithelial cells leads to inhibition in thiamin uptake via effects on physiological and molecular parameters of hTHTR-1 and -2. Furthermore, the inhibition appears to be dependent on a functional TTSS of EPEC.

摘要

肠致病性大肠杆菌(EPEC)是一种食源性病原体,感染该病原体对人类健康构成重大威胁。虽然腹泻是这种感染的主要后果,但营养不良也会发生,尤其是在严重和长期的情况下,这可能会使感染宿主的健康状况恶化。在这里,我们使用已建立的人肠上皮 Caco-2 细胞模型研究了 EPEC 感染对水溶性维生素 B1(硫胺素)肠内摄取的影响。结果表明,用野生型 EPEC 感染 Caco-2 细胞(而非无致病性大肠杆菌、失活的 EPEC 或过滤上清液)会导致硫胺素摄取显著(P < 0.01)抑制。EPEC 感染还影响了纳米摩尔(由 THTR-2 介导)和微摩尔(由 THTR-1 介导)硫胺素摄取过程的动力学参数。通过生物素化法测定的 hTHTR-1 和 -2 蛋白的细胞表面表达在 EPEC 处理的细胞中明显(P < 0.01)低于对照。EPEC 感染还影响了 SLC19A2 和 SLC19A3 基因的稳态 mRNA 水平和启动子活性。感染带有 escN 基因突变(该基因编码 EPEC 型 III 型分泌系统(TTSS)的假定 ATP 酶)或 espA、espB 或 espD 基因突变(编码 TTSS 结构成分)的 EPEC 突变体的 Caco-2 细胞不会影响硫胺素摄取。另一方面,espF 和 espH 基因突变(编码效应蛋白)表现出硫胺素摄取的部分抑制。这些结果首次证明,EPEC 感染人肠上皮细胞会通过对 hTHTR-1 和 -2 的生理和分子参数产生影响,导致硫胺素摄取抑制。此外,这种抑制似乎依赖于 EPEC 的功能性 TTSS。

相似文献

1
Enteropathogenic Escherichia coli inhibits intestinal vitamin B1 (thiamin) uptake: studies with human-derived intestinal epithelial Caco-2 cells.肠致病性大肠杆菌抑制肠道维生素 B1(硫胺素)摄取:用人源肠上皮 Caco-2 细胞进行的研究。
Am J Physiol Gastrointest Liver Physiol. 2009 Oct;297(4):G825-33. doi: 10.1152/ajpgi.00250.2009. Epub 2009 Jul 23.
2
Enteropathogenic Escherichia coli inhibits butyrate uptake in Caco-2 cells by altering the apical membrane MCT1 level.肠致病性大肠杆菌通过改变顶端膜单羧酸转运蛋白1(MCT1)的水平来抑制Caco-2细胞对丁酸盐的摄取。
Am J Physiol Gastrointest Liver Physiol. 2006 Jan;290(1):G30-5. doi: 10.1152/ajpgi.00302.2005. Epub 2005 Sep 8.
3
Enterotoxigenic Escherichia coli infection and intestinal thiamin uptake: studies with intestinal epithelial Caco-2 monolayers.肠产毒性大肠杆菌感染与肠道硫胺素摄取:用肠上皮 Caco-2 单层细胞进行的研究。
Am J Physiol Cell Physiol. 2013 Dec 1;305(11):C1185-91. doi: 10.1152/ajpcell.00276.2013. Epub 2013 Oct 16.
4
Differentiation-dependent up-regulation of intestinal thiamin uptake: cellular and molecular mechanisms.肠道硫胺素摄取的分化依赖性上调:细胞和分子机制
J Biol Chem. 2005 Sep 23;280(38):32676-82. doi: 10.1074/jbc.M505243200. Epub 2005 Jul 29.
5
Enteropathogenic Escherichia coli Infection Inhibits Intestinal Ascorbic Acid Uptake via Dysregulation of Its Transporter Expression.肠致病性大肠杆菌感染通过其转运蛋白表达失调抑制肠道抗坏血酸摄取。
Dig Dis Sci. 2021 Jul;66(7):2250-2260. doi: 10.1007/s10620-020-06389-x. Epub 2020 Jun 17.
6
Enteropathogenic Escherichia coli (EPEC) adhesion to intestinal epithelial cells: role of bundle-forming pili (BFP), EspA filaments and intimin.肠致病性大肠杆菌(EPEC)对肠道上皮细胞的黏附:束状菌毛(BFP)、EspA细丝和紧密黏附素的作用
Microbiology (Reading). 2004 Mar;150(Pt 3):527-538. doi: 10.1099/mic.0.26740-0.
7
Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expression.肠道致病性大肠杆菌感染会抑制肠道5-羟色胺转运体的功能和表达。
Gastroenterology. 2009 Dec;137(6):2074-83. doi: 10.1053/j.gastro.2009.09.002. Epub 2009 Sep 10.
8
Enteropathogenic Escherichia coli inhibits ileal sodium-dependent bile acid transporter ASBT.肠致病性大肠杆菌抑制回肠钠依赖性胆汁酸转运体 ASBT。
Am J Physiol Gastrointest Liver Physiol. 2012 May 15;302(10):G1216-22. doi: 10.1152/ajpgi.00017.2012. Epub 2012 Mar 8.
9
Translocation of enteropathogenic Escherichia coli across an in vitro M cell model is regulated by its type III secretion system.肠道致病性大肠杆菌通过体外M细胞模型的易位受其三型分泌系统调控。
Cell Microbiol. 2007 Jun;9(6):1538-46. doi: 10.1111/j.1462-5822.2007.00891.x. Epub 2007 Feb 9.
10
Bacterial lipopolysaccharide inhibits free thiamin uptake along the intestinal tract via interference with membrane expression of thiamin transporters 1 and 2.细菌脂多糖通过干扰肠道中硫胺素转运蛋白 1 和 2 的膜表达来抑制游离硫胺素的摄取。
Am J Physiol Cell Physiol. 2024 Nov 1;327(5):C1163-C1177. doi: 10.1152/ajpcell.00570.2024. Epub 2024 Sep 9.

引用本文的文献

1
Bacterial lipopolysaccharide inhibits free thiamin uptake along the intestinal tract via interference with membrane expression of thiamin transporters 1 and 2.细菌脂多糖通过干扰肠道中硫胺素转运蛋白 1 和 2 的膜表达来抑制游离硫胺素的摄取。
Am J Physiol Cell Physiol. 2024 Nov 1;327(5):C1163-C1177. doi: 10.1152/ajpcell.00570.2024. Epub 2024 Sep 9.
2
Intermediate role of gut microbiota in vitamin B nutrition and its influences on human health.肠道微生物群在维生素B营养中的中间作用及其对人类健康的影响。
Front Nutr. 2022 Dec 13;9:1031502. doi: 10.3389/fnut.2022.1031502. eCollection 2022.
3
Infection With Pathotypes Is Associated With Biomarkers of Gut Enteropathy and Nutritional Status Among Malnourished Children in Bangladesh.在孟加拉国营养不良的儿童中,与肠道病理学感染相关的生物标志物与营养状况有关。
Front Cell Infect Microbiol. 2022 Jul 6;12:901324. doi: 10.3389/fcimb.2022.901324. eCollection 2022.
4
Pathophysiology of enteropathogenic during a host infection.宿主感染期间肠致病性 的病理生理学。
J Vet Sci. 2022 Mar;23(2):e28. doi: 10.4142/jvs.21160. Epub 2022 Jan 27.
5
What We Know So Far about the Metabolite-Mediated Microbiota-Intestinal Immunity Dialogue and How to Hear the Sound of This Crosstalk.目前我们对代谢物介导的微生物群-肠道免疫对话的了解以及如何聆听这种相互作用的声音。
Metabolites. 2021 Jun 21;11(6):406. doi: 10.3390/metabo11060406.
6
Enteropathogenic Escherichia coli Infection Inhibits Intestinal Ascorbic Acid Uptake via Dysregulation of Its Transporter Expression.肠致病性大肠杆菌感染通过其转运蛋白表达失调抑制肠道抗坏血酸摄取。
Dig Dis Sci. 2021 Jul;66(7):2250-2260. doi: 10.1007/s10620-020-06389-x. Epub 2020 Jun 17.
7
Environment Controls LEE Regulation in Enteropathogenic .环境控制肠道致病菌中的李氏菌调控
Front Microbiol. 2018 Jul 27;9:1694. doi: 10.3389/fmicb.2018.01694. eCollection 2018.
8
Inhibition of Intestinal Thiamin Transport in Rat Model of Sepsis.脓毒症大鼠模型中肠道硫胺素转运的抑制作用
Crit Care Med. 2016 Sep;44(9):e875-81. doi: 10.1097/CCM.0000000000001745.
9
Enterotoxigenic Escherichia coli infection and intestinal thiamin uptake: studies with intestinal epithelial Caco-2 monolayers.肠产毒性大肠杆菌感染与肠道硫胺素摄取:用肠上皮 Caco-2 单层细胞进行的研究。
Am J Physiol Cell Physiol. 2013 Dec 1;305(11):C1185-91. doi: 10.1152/ajpcell.00276.2013. Epub 2013 Oct 16.
10
Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.人类肠致病性细菌的发病机制:从培养的、完全分化的人结肠癌细胞系中得到的启示。
Microbiol Mol Biol Rev. 2013 Sep;77(3):380-439. doi: 10.1128/MMBR.00064-12.

本文引用的文献

1
Pathogenic bacteria induce colonic PepT1 expression: an implication in host defense response.致病细菌诱导结肠肽转运体1表达:对宿主防御反应的一种影响
Gastroenterology. 2009 Oct;137(4):1435-47.e1-2. doi: 10.1053/j.gastro.2009.06.043. Epub 2009 Jun 21.
2
Malnutrition as an enteric infectious disease with long-term effects on child development.营养不良作为一种对儿童发育有长期影响的肠道传染病。
Nutr Rev. 2008 Sep;66(9):487-505. doi: 10.1111/j.1753-4887.2008.00082.x.
3
Human copper transporter hCTR1 mediates basolateral uptake of copper into enterocytes: implications for copper homeostasis.人类铜转运蛋白hCTR1介导铜从基底外侧摄取进入肠上皮细胞:对铜稳态的影响。
J Biol Chem. 2007 Sep 7;282(36):26471-80. doi: 10.1074/jbc.M702653200. Epub 2007 Jul 12.
4
Mechanism underlying inhibition of intestinal apical Cl/OH exchange following infection with enteropathogenic E. coli.肠道致病性大肠杆菌感染后肠道顶端Cl/OH交换抑制的潜在机制。
J Clin Invest. 2007 Feb;117(2):428-37. doi: 10.1172/JCI29625. Epub 2007 Jan 25.
5
Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair.大肠杆菌Nissle 1917益生菌作用的分子机制涉及ZO-2和PKCζ的重新分布,从而导致紧密连接和上皮屏障修复。
Cell Microbiol. 2007 Mar;9(3):804-16. doi: 10.1111/j.1462-5822.2006.00836.x. Epub 2006 Nov 3.
6
Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins.由三种肠道致病性大肠杆菌注入的效应蛋白协同作用介导的强效致腹泻机制。
Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1876-81. doi: 10.1073/pnas.0509451103. Epub 2006 Jan 30.
7
Targeting and trafficking of the human thiamine transporter-2 in epithelial cells.人硫胺素转运蛋白2在上皮细胞中的靶向定位与运输
J Biol Chem. 2006 Feb 24;281(8):5233-45. doi: 10.1074/jbc.M512765200. Epub 2005 Dec 21.
8
Enteropathogenic Escherichia coli inhibits butyrate uptake in Caco-2 cells by altering the apical membrane MCT1 level.肠致病性大肠杆菌通过改变顶端膜单羧酸转运蛋白1(MCT1)的水平来抑制Caco-2细胞对丁酸盐的摄取。
Am J Physiol Gastrointest Liver Physiol. 2006 Jan;290(1):G30-5. doi: 10.1152/ajpgi.00302.2005. Epub 2005 Sep 8.
9
Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier.肠道致病性大肠杆菌EspG破坏微管,并与Orf3共同增强紧密连接屏障的扰动。
Mol Microbiol. 2005 Apr;56(2):447-64. doi: 10.1111/j.1365-2958.2005.04571.x.
10
Characterization of the 5'-regulatory region of the human thiamin transporter SLC19A3: in vitro and in vivo studies.人类硫胺素转运蛋白SLC19A3的5'-调控区域的特征:体外和体内研究
Am J Physiol Gastrointest Liver Physiol. 2004 Oct;287(4):G822-9. doi: 10.1152/ajpgi.00234.2004. Epub 2004 Jun 24.